ClinicalTrials.gg
CompletedNCT04011696MERoVUpdated Nov 3, 2023

Monofocal Extended Range of Vision (MERoV) Study

An observational study in Pseudophakia, Accomodation and Aberration, Corneal Wavefront, sponsored by Brighton and Sussex University Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-03.

Sponsored by Brighton and Sussex University Hospitals NHS Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
412
Ages
18 Years and older
Sex
All
01

Study summary

The investigators are proposing this research project to:

  1. Screen a set of patients after normal cataract surgery with a single focus lens aimed at good distance vision at 3 months after surgery to identify patients who are able to see and read well without glasses.
  2. Identify the combination of factors responsible for this phenomenon in the patients who are achieving this.

Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. At 3 months after surgery they will have their un-corrected vision checked. They will also have their reading speed assessed without any glasses. They will undergo a through refractive check by an optometrist to assess the power of the spectacles (if needed) and following this they will have a scan of the eye (a technique known as wave front analysis which uses very sophisticated optics) to capture the optical distortions in the structures of the eye.

If this study is able identify factor/s responsible for giving good unaided reading and distance vision then this factor can be reproduced in eyes undergoing cataract surgery. This will mean that the patients can have an increased option of spectacle independence without the need for expensive multifocal IOLs and their associated side effects such as glare and halos, particularly at night.

Read the detailed description

TYPE OF THE STUDY:

A prospective, non-blinded, non-randomized, single eye cohort study in patients who had uneventful cataract surgery with a monofocal IOL.

Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery.

Inclusion criteria

  1. Uneventful cataract surgery
  2. Sequential recruitment
  3. Potential to see 20/40 (6/12) unaided or better postoperatively
  4. No significant macular pathology
  5. Willing to follow up at 3 months

Exclusion criteria

  1. Patients under 20 years of age
  2. Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries)
  3. Posterior capsule opacification
  4. Inability to read English text or physically or mentally unable to cooperate with the postoperative assessment

At 3 months, uniocular unaided distance LogMAR acuity will be recorded. An OCT scan will be performed to establish macular integrity. Pupil size, manifest refraction, measurement of any deviations of the optical rays (called as wavefront aberrometry) will be performed using a iTrace (Tracy Technology) wavefront aberrometer. Unaided reading speed and critical print size will be measured using a Salzberg Reading Desk. Examination time per patient: 40 mins in total. Multivariate statistical analysis will be performed. Power calculation showed a need to examine 412 patients.

02

Conditions studied

  • Pseudophakia
  • Accomodation
  • Aberration, Corneal Wavefront

Browse trials for

Keywords

  • pseudoaccommodation
  • monofocal IOL
  • cataract surgery
03

In context

Pseudophakia

54 studies on the registry are indexed under Pseudophakia; 8 are open to participants now.

This study's enrollment of 412 is above the median of 71 across 26 observational studies indexed under Pseudophakia.

Browse Pseudophakia studies →

Lead sponsor

Brighton and Sussex University Hospitals NHS Trust is the lead sponsor of 22 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

For the purpose of this research, the notes of all the patient undergoing routine NHS cataract surgery will be assessed by the research nurse to see if they have a potential to have 6/12 or better vision after cataract surgery. If so, they will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Uneventful cataract surgery, sequential recruitment, potential to see 20/40 (6/12) unaided or better postoperatively, no significant macular pathology and willing to follow up at 3 months.

Exclusion criteria

Exclusion Criteria:

  • Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries), posterior capsule opacification,inability to read English text or physically or mentally unable to and cooperate with the postoperative assessment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
412 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Uncorrected distance and near vision

    Uncorrected distance of 20/40 and near of J4

    Time frame: 3 months postoperatively

Secondary outcomes

  1. Spherical error

    Spherical error on manifest refraction

    Time frame: 3 months postoperatively

  2. astigmatic error

    astigmatic error on manifest refraction

    Time frame: 3 months postoperatively

  3. Pupil size

    Pupil size in mesopic condition

    Time frame: 3 months postoperatively

  4. Total spherical and vertical coma aberrations

    Total spherical and vertical coma aberrations on aberrometry

    Time frame: 3 months postoperatively

  5. Reading speed and critical font size

    Measured on Salzburg's reading desk

    Time frame: 3 months postoperatively

07

Study locations

1 site
  • Mayank Nanavaty
    Brighton, BN2 5BF, United Kingdom
08

References and documents

Publications

  • Nanavaty MA, Vasavada AR, Patel AS, Raj SM, Desai TH. Analysis of patients with good uncorrected distance and near vision after monofocal intraocular lens implantation. J Cataract Refract Surg. 2006 Jul;32(7):1091-7. doi: 10.1016/j.jcrs.2006.03.021. PubMed 16857493 ↗
  • Nanavaty MA, Spalton DJ, Boyce J, Saha S, Marshall J. Wavefront aberrations, depth of focus, and contrast sensitivity with aspheric and spherical intraocular lenses: fellow-eye study. J Cataract Refract Surg. 2009 Apr;35(4):663-71. doi: 10.1016/j.jcrs.2008.12.011. PubMed 19304086 ↗
  • Nanavaty MA, Spalton DJ, Marshall J. Effect of intraocular lens asphericity on vertical coma aberration. J Cataract Refract Surg. 2010 Feb;36(2):215-21. doi: 10.1016/j.jcrs.2009.08.024. PubMed 20152600 ↗

Individual participant data

Plan to share: No — The data will be collected in paper files and NHS computers. No external agency will have access to the study data.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04011696
Lead sponsor
Brighton and Sussex University Hospitals NHS Trust
Collaborators
King's College London, European Society of Cataract and Refractive Surgeons
Responsible party
Sponsor
First posted
Jul 8, 2019
Start date
Jul 3, 2019
Primary completion
May 31, 2022
Completion
May 31, 2022
Last update
Nov 3, 2023

Study contacts

Mayank A Nanavaty, FRCOphth,PhD
study chair · Brighton and Sussex University Hospitals NHS Trust
David J Spalton, FRCOphth
principal investigator · King's College London
Catey Bunce, DSc
principal investigator · King's College London

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion